Leaflet TELZIR 50mg / ml oral suspension


Indicated for: HIV-1 infection

Route of administration: oral

Substance: fosamprenavir (protease inhibitor)

ATC: J05AE07 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)

Fosamprenavir is an antiviral medication used to treat HIV-1 infection in adults and adolescents. It belongs to the class of protease inhibitors and works by blocking an enzyme essential for the multiplication of the HIV virus, thus helping to reduce the viral load in the body.

Fosamprenavir is taken orally as tablets or suspension, usually in combination with other antiretroviral drugs. The dose and treatment schedule are determined by your doctor based on age, weight, and response to therapy. It is important to follow medical instructions strictly to prevent the development of viral resistance.

Side effects may include nausea, diarrhea, headache, skin rashes, or changes in liver function. In rare cases, severe allergic reactions or metabolic problems may occur. Any unusual symptoms should be reported to your doctor immediately.

Fosamprenavir is an effective medication for controlling HIV infection, but it requires careful medical monitoring and strict adherence to treatment. Do not stop therapy without your doctor's approval to ensure the effectiveness and safety of the treatment.

General data about TELZIR 50mg / ml

  • Substance: fosamprenavir
  • Date of last drug list: 01-07-2020
  • Commercial code: W61526001
  • Concentration: 50mg / ml
  • Pharmaceutical form: oral suspension
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for fosamprenavir

Concentrations available for fosamprenavir

  • 50mg/ml
  • 700mg